Marcaine Adrenaline

Bupivacaine hydrochloride and epinephrine, the active ingredient in Marcaine Adrenaline, is a local anesthetic presented as a solution for injection for epidural and infiltration use. It provides regional anesthesia for surgical procedures in adult patients. GNH USA supplies Marcaine Adrenaline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Marcaine Adrenaline is a local anesthetic used in various surgical and procedural settings. - Surgical procedures: provides reliable local anesthesia for incisions and operative sites. - Epidural anesthesia: enables pain control during labor or major surgeries requiring segmental block. - Infiltration anesthesia: allows targeted numbing of tissue during minor or outpatient procedures.

Marcaine Adrenaline may cause a range of adverse reactions.

Common Side Effects: - Transient pain or burning at the injection site - Tachycardia - Hypertension - Nausea

Serious or Rare Side Effects: - Cardiac arrhythmia - Seizures - Severe hypotension - Allergic reaction (anaphylaxis)

When using Marcaine Adrenaline, clinicians should observe several safety measures. - Allergy assessment: confirm no hypersensitivity to bupivacaine, epinephrine, or amide‑type anesthetics. - Cardiovascular status: avoid in patients with uncontrolled hypertension or significant cardiac disease. - Dosage limits: adhere to maximum recommended dose to prevent systemic toxicity. - Concurrent CNS depressants: monitor for additive central nervous system effects. - Pregnancy and lactation: use only if the anticipated benefit justifies potential risk. - Store at ambient temperature: keep below 25°C, protect from light and moisture, retain in original container.

Marcaine Adrenaline can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Beta‑blockers: may potentiate epinephrine‑induced hypertension and tachycardia. - Class I antiarrhythmics (e.g., quinidine): increase risk of cardiac toxicity. - Other local anesthetics: additive systemic toxicity risk.

Moderate Interactions (Monitor Closely): - Monoamine oxidase inhibitors: may enhance epinephrine effects. - Diuretics: may alter plasma concentration of bupivacaine. - General anesthetics: monitor for prolonged sedation or respiratory depression.